Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Heregulin beta 1 Protein (AA 177-241)

Origin: Human Host: Escherichia coli (E. coli) Recombinant >98 % , as determined by Coomassie stained SDS-PAGE. FACS Active
Catalog No. ABIN2667430
  • Target See all Heregulin beta 1 products
    Heregulin beta 1
    Protein Type
    Recombinant
    Biological Activity
    Active
    Protein Characteristics
    AA 177-241
    Origin
    Human
    Source
    • 1
    Escherichia coli (E. coli)
    Application
    Flow Cytometry (FACS)
    Purity
    >98 % , as determined by Coomassie stained SDS-PAGE.
    Endotoxin Level

    Less than 0.1 ng per μg of protein.

  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Comment

    Biological activity: ED50 ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2.0 x 106 units/mg, as measured by its ability to stimulate proliferation of human MCF7 cells in a dose dependent manner.

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    For maximum results, quick spin vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/mL. Do not vortex. It is recommended to further dilute in a buffer, such as 5 % Trehalose, and store working aliquots at -20 °C to -80 °C.
    Buffer
    Lyophilized, carrier-free.
    Handling Advice
    Avoid repeated freeze/thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Unopened vial can be stored at -20°C or -70°C.
  • Target
    Heregulin beta 1
    Alternative Name
    Heregulin-Beta1 (Heregulin beta 1 Products)
    Background
    Heregulin, also named neuregulin-1 type I, is a family of growth factors that act as ligands for the epidermal growth factor receptors, including ERBB3 and ERBB4. Heregulins regulate survival, proliferation, and differentiation of the cells during development and wound healing. Heregulin-β1 is one of the Heregulin isoforms derived from alternative splicing. Binding of Heregulin-β1 to receptor tyrosine kinases ERBB3 or ERBB4 results in the recruitment and activation of ERBB2, subsequently transducing signaling cascades through the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K) pathways. It has been suggested that heregulin-β1 participates in the tumorgenesis and metastasis of breast cancer, promoting proliferation, migration, and invasion of breast cancer cells.
    Molecular Weight
    The 65 amino acid recombinant protein has a predicted molecular mass of approximately 7.5 kDa. The predicted N-terminal acid is Ser.
You are here:
Support